Auditory event-related potentials (P300) in partial and generalized epileptic patients  by Soysal, A. et al.
Article No. seiz.1998.0234, available online at http://www.idealibrary.com on
Seizure 1999; 8: 107 –110
Auditory event-related potentials (P300) in partial and
generalized epileptic patients
Aysun Soysal, DI˙lek Atakli, Turan Atay, HÜlya Altintas, SevI˙m Baybas &
BakI˙ ArpacI
Department of Neurology, Bakırko¨y State Hospital for Psychiatric and Neurological Diseases, ˙Istanbul,
Turkey
Correspondence to: Dr Aysun Soysal, Bakırko¨y Ruh ve Sinir Hastaliklari Hastanesi, 1. No¨roloji Klinig˘i 34747
Bakırko¨y/˙Istanbul, Turkey
We evaluated the P300 components of event-related potentials (ERP) in 64 cryptogenic partial epilepsy (CPE) patients, and
52 idiopathic generalized epilepsy (IGE) patients as well as in their age-matched control groups. The P200, N200 and P300
latencies recorded from Cz were significantly longer in CPE patients compared with those of their control group (P D 0:0371,
P D 0:0092 and P D 0:0405, respectively). The P200 and N200 latencies recorded from Fz were significantly longer than in
their control group (P D 0:0448 and P D 0:0107) while the prolongation in the P300 latencies was not found to be statistically
significant (P D 0:0733). All latencies were longer in IGE patients, and the amplitudes of the N200/P300 components of
ERP were lower in both epileptic groups compared with their control groups, but these differences were not significant. The
prolongation of the P300 latencies was not correlated with the type or serum level of antiepileptic drug or seizure control. Our
findings suggest that the prolongation of the P300 latency of ERP is related to the type of epilepsy.
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The P300 component of event-related potentials
(ERPs) is generated when a subject attends and dis-
criminates between two different stimuli, one of which
is presented infrequently1–4. It was first described by
Sutton in 19655–8. Since then, many investigations have
focused on P300 generators and their relationships with
cognitive functions9–12. The hippocampus, thalamus
and frontal lobe have been considered as possible loca-
tions of the P300 generators1–3, 6, 7, 11, 13–21. As a result,
it has been emphasized that P300 might represent the
sum of the activities of many different generators7, 20.
It is also known that various neurological disor-
ders including epilepsy are accompanied by cogni-
tive impairment that is related to the latency of the
P300 component1–3, 7, 8, 13, 15–24. Various degrees of
cognitive impairment have been reported in different
epileptic syndromes2, 7, 8, 13, 15, 16, 18, 20, 22, 24. We aimed
to evaluate the latency and amplitude of the P300
component of auditory ERP in epileptic patients with
cryptogenic partial epilepsy and idiopathic generalized1059–1311/99/020107 + 04 $12.00/0seizures, and compare them with those of volunteer,
age-matched, healthy controls.
Materials and methods
Sixty-four (35 men and 29 women) cryptogenic partial
epilepsy (CPE) patients and 52 (19 men and 33 women)
idiopathic generalized epilepsy (IGE) patients were
studied at the epilepsy outpatient clinic of Bakırko¨y
State Hospital for Neurological and Psychiatric Dis-
eases. All patients were selected according to the cri-
teria of the ILAE. The mean age was 19:56  6:09
years (ranging from 12 to 43 years) for IGE, and
25:64 10:75 years (ranging from 15 to 54 years) for
the CPE group. There was no structural lesion in cranial
CT/MRI investigations of patients with partial epilepsy.
In the CPE group, 21 patients had been treated with
phenytoin (PHT), 40 with carbamazepine (CBZ) and
three with valproic acid (VPA); and in the IGE group
four with PHT, two with CBZ, one with phenobarbital
(PB) and 45 with VPA. The seizures of 10 IGE andc© 1999 British Epilepsy Association
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antiepileptic drugs. Their antiepileptic serum drug lev-
els were in therapeutic ranges and none of the patients
showed the stigma of intoxication. Since the mean age
of the IGE patients was significantly lower than that
of the CPE patients, we had to use two different age-
matched control groups of healthy volunteers for each
study group. The control groups for IGE and CPE con-
sisted of 15 (eight men and seven women; the mean
age was 22:00  6:64 years, ranging from 12 to 32
years) and 20 (10 men and 10 women; the mean age
was 24:85  7:71 years, ranging from 12 to 35 years)
individuals, respectively.
ERPs were studied by using a Medelec Sapphire
4ME device. Binaural auditory stimuli were presented
by earphones. Fifteen percent of stimuli were rare (tar-
get) tones of 1000 Hz (95 dB) whereas the remainder
were frequent (nontarget) tones of 8000 Hz (95 dB).
The stimulus sequence was random.
ERPs were recorded at Fz and Cz using Ag/AgCl
electrodes which were referred to linked mastoids, ac-
cording to a 10–20 system. All the electrodes had a
resistance of 2 k or less and the filter bandpass was
0.1–50 Hz. Randomized, artifact free, 32 target and 168
nontarget stimuli were averaged simultaneously and
separately. Data from the two trials were obtained con-
secutively and stored. The latency and the amplitude
of the P300 component of the target averages recorded
at Fz and Cz were measured.
Patients and control subjects were seated on a com-
fortable chair in a quiet room with their eyes lightly
closed, and requested to count the number of rare tones.
Prior to the recordings, experimental procedures were
explained to the subjects, a short test was given to be
sure that the patients understood the instructions, and
then recordings were taken.
The latency of the N100, P200, N200, P300
responses and the amplitude of the N100/P200,
P200/N200, N200/P300 responses to rare tone stim-
ulation were measured with cursors, and the results of
the patients were compared with those of their control
groups using Student’s t-test, the Mann Whitney U -test
and Pearson correlation tests.
Results
Table 1 shows the N100, P200, N200 and P300
latencies and Table 2 summarizes the N100/P200,
P200/N200 and N200/P300 amplitudes of the P300
components of auditory ERPs recorded from Fz and
Cz in the IGE/CPE patients and their control groups.
In the CPE group, the P2, N2 and P3 latencies recorded
from Cz were significantly longer than in their control
group (P D 0:0371, P D 0:0092 and P D 0:0405,
respectively). The P200 and N200 latencies recordedfrom Fz were significantly longer than their control
group (P D 0:0448 and P D 0:0107); the P300
latencies were longer than in their control group as
well, but this difference was not found to be significant
(P D 0:0733). All latencies were longer in IGE pa-
tients than in their control group. However, there was
no significant difference between the IGE patients and
their control group. In both epileptic groups, the am-
plitudes of the N200/P300 components recorded from
Fz and Cz were lower than their control groups; these
however, were not found to be significant.
When considering the changes in the latencies and
amplitudes of the P300 components among epileptic
patients with controlled or uncontrolled seizures, no
differences were found. Again, no specific effect re-
sulting from the type or serum level of the antiepileptic
medications was noticed.
Discussion
In the literature, it has been reported that there are
some abnormalities in the P300 component of ERPs in
epileptic patients. However, the results are controver-
sial. Drake et al.13 reported increased P300 latencies
in patients with complex partial seizures and partial
seizures with secondary generalization. Fukai et al.7
found that the P300 latencies were significantly longer
in temporal lobe epilepsy (TLE) patients compared
with those of IGE patients and their control groups.
Nelson et al.16 noted variability in the amplitude and la-
tency of the P300 component during pre-surgical eval-
uation of temporal lobectomy patients. Puce et al.2 re-
ported that the limbic P300 potential was absent or
rudimentary on the site of the focus in 48 of 59 patients
(81%) having TLE. As a result, all the investigators
mentioned above have hypothesized that the hippocam-
pus might play an important role in the generation of
the P300. On the other hand, Rugg et al.18 reported
that the P300s were symmetrical and of normal ampli-
tude in a patient with a low grade infiltrating glioma
which involved the full extent of the left medial tem-
poral lobe. Thus, they claimed that it was difficult to
support the hypothesis suggesting that the hippocam-
pus, or any other medial temporal structure, makes a
substantial contribution to the scalp P300. In another
study, Sunage et al.20 examined the P300 latencies in
children with IGE and TLE, and found prolonged P300
latencies in IGE patients. They speculated that the dys-
function of the mesencephalic reticular formation and
thalamus may play major roles in the genesis of gen-
eralized epilepsy, and thus, in the prolongation of the
P300 latencies. However, the impact of the antiepilep-
tic therapy on the P300 latencies in Sunago’s study was
not apparently discussed.
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Table 1: The latencies of P300 components of auditory ERPs recorded from Fz and Cz in IGE epilepsy patients and CPE patients
and their control groups.
Wave form IGE Control P CPE Control P
FzN100 138:4 34:5 137:7 27:3 0.9520 144:8 38:7 132:9 28:9 0.4947
FzP200 180:1 3:2 178:4 26:7 0.8390 192:0 35:2 171:3 29:1 0.0448
FzN200 223:3 40:2 219:8 27:0 0.5523 235:7 38:1 211:6 32:4 0.0107
FzP300 320:9 33:2 317:0 16:6 0.8039 337:4 56:4 316:5 33:0 0.0733
CzN100 137:1 35:7 137:2 27:2 0.9520 143:5 38:7 133:0 28:4 0.4980
CzP200 179:9 40:0 176:7 26:6 0.9940 190:5 37:0 169:7 29:0 0.0371
CzN200 221:4 41:1 214:9 26:7 0.4889 232:6 39:2 207:4 31:9 0.0092
CzP300 318:7 33:3 314:3 14:6 0.7634 336:3 55:5 314:8 29:2 0.0405
Table 2: The amplitudes of P300 components of auditory ERPs recorded from Fz and Cz in IGE epilepsy patients and CPE
patients and their control groups.
Wave form IGE Control P CPE Control P
FzN100/P200 7:44 5:18 7:47 3:46 0.5778 7:79 4:02 6:49 3:55 0.1954
FzP200/N200 −7:03 4:83 −6:51 4:01 0.8745 −6:16 3:91 −6:05 3:67 0.9247
FzN200/P300 17:44 8:33 19:87 6:52 0.1856 18:0 11:1 20:2 8:09 0.1840
CzN100/P200 8:91 6:54 9:15 5:59 0.6736 9:17 5:36 7:93 5:43 0.3184
CzP200/N200 −7:07 5:22 −7:29 4:96 0.7924 −6:12 4:19 −6:79 4:56 0.6365
CzN200/P300 19:8 10:14 20:8 6:04 0.2924 19:8 9:86 20:1 6:15 0.6216
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